Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 12/2010

01-12-2010 | Short Communication

Head and neck squamous cell cancers: need for an organised time-bound surveillance plan

Authors: Rehan Kazi, Kapila Manikanthan, K. A. Pathak, Raghav C. Dwivedi

Published in: European Archives of Oto-Rhino-Laryngology | Issue 12/2010

Login to get access

Abstract

Optimal care of patients with head and neck squamous cell cancer (HNSCC) involves a pre-determined period of post-treatment follow-up for the detection of recurrent or persistent disease, metastases and second primaries at the earliest opportunity. There is little evidence in literature as to whether the surveillance schemes should be based on patient survival, quality of life or cost-adjusted parameters. This article aims at highlighting some of the issues pertinent to the optimization of surveillance strategies in HNSCC.
Literature
1.
Ridge JA (1993) Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 20:419–429PubMed
2.
DeVisscher AVM, Manni JJ (1994) Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Arch Otolaryngol Head Neck Surg 120:934–939
3.
Loree TR (1997) Head and neck carcinoma: counterpoint. In: Johnson FE, Virgo KS (eds) Cancer patient follow-up. Mosby–Year Book Inc, St. Louis, p 72.13
4.
Coniglio JU, Netterville JL (1993) Guidelines for patient management. In: Bailey BJ, Johnson JT, Pillsbury HC, Kohut RI, Tardy ME Jr (eds) Head and neck surgery otolaryngology. JB Lippincott, Philadelphia, pp 1021–1028
5.
Clinical Practice Guidelines Task Force (1996) Clinical practice guidelines for the diagnosis and management of cancer of the head and neck. The American Society for Head and Neck Surgery, Pittsburgh, PA, Society of Head and Neck Surgeons, Arlington, VA
6.
British Association of Head and Neck Oncologists (2001) Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol 27(Suppl A):S1–S17
7.
Boysen M, Lövdal O, Tausjö J, Winther F (1992) The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28:426–430CrossRefPubMed
8.
Schwartz DL, Barker J Jr, Chansky K et al (2003) Postradiotherapy surveillance practice for head and neck squamous cell carcinoma–too much or too little? Head Neck 25:990–999CrossRefPubMed
9.
Johnson FE, Johnson MH, Clemente MF, Paniello RC, Virgo KS (2006) Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol 13:1063–1071CrossRefPubMed
10.
Mukherji SK, Mancuso AA, Kotzur IM et al (1994) Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology 193:149–154PubMed
11.
O’Meara WP, Thiringer JK, Johnstone PA (2003) Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 66:323–326CrossRefPubMed
12.
Schoder H, Yeung HWD, Gonen M et al (2004) Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231:65–72CrossRefPubMed
13.
Abgral R, Querellou S, Potard G et al (2009) Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50:24–29CrossRefPubMed
14.
Haughey BH, Gates GA, Arfken CL, Harvey J (1992) Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101:105–112PubMed
15.
Cetinayak O, Akman F, Kentli S et al (2008) Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 94:19–23PubMed
16.
Virgo KS, Paniello RC, Johnson FE (1998) Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124:564–572PubMed
Metadata
Title
Head and neck squamous cell cancers: need for an organised time-bound surveillance plan
Authors
Rehan Kazi
Kapila Manikanthan
K. A. Pathak
Raghav C. Dwivedi
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 12/2010
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1377-x

Other articles of this Issue 12/2010

European Archives of Oto-Rhino-Laryngology 12/2010 Go to the issue

Head and Neck

Fear of recurrence following head and neck cancer in the outpatient clinic

Miscellaneous

Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology

Review Article

Thyroid and parathyroid surgery in pregnancy

Head and Neck

Temporal bone verrucous carcinoma: outcomes and treatment controversy

Rhinology

Sensation of nasal patency compared to rhinomanometric results after septoplasty

Laryngology

New approach to diagnose arytenoid dislocation and subluxation using three-dimensional computed tomography